Atox Bio Overview

  • Year Founded
  • 2002

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Out of Business

Atox Bio General Information

Description

Developer of novel immunomodulators intended to improve outcomes for serious, unmet medical conditions in the critical care setting. The company treats a rare, life-threatening infection with elevated morbidity and mortality whose results have shown a meaningful improvement across multiple endpoints, enabling healthcare institutions to improve the host's ability to effectively fight the infection and reduce the tissue damage caused to key organs during acute inflammatory situations.

Contact Information

Website
www.atoxbio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 1000 Park Forty Plaza
  • Suite 210
  • Durham, NC 27713
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1000 Park Forty Plaza
  • Suite 210
  • Durham, NC 27713
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Atox Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Out of Business 31-Dec-2019 Completed Out of Business
6. Later Stage VC (Series F) 30-Apr-2019 Completed Generating Revenue
5. Later Stage VC (Series E) 24-Jul-2014 Completed Generating Revenue
4. Later Stage VC 19-Dec-2011 Completed Generating Revenue
3. Angel (individual) 13-Oct-2010 Completed Generating Revenue
2. Angel (individual) Completed Startup
1. Grant 01-Apr-2002 $6.5M Completed Startup
To view Atox Bio’s complete valuation and funding history, request access »

Atox Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel immunomodulators intended to improve outcomes for serious, unmet medical conditions in the critical c
Drug Discovery
Durham, NC
10 As of 2022

Cambridge, MA

New York, NY
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Atox Bio Competitors (47)

One of Atox Bio’s 47 competitors is AnTolRx, a Formerly VC-backed company based in Cambridge, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
AnTolRx Formerly VC-backed Cambridge, MA
Xalud Therapeutics Venture Capital-Backed New York, NY
Parion Sciences Venture Capital-Backed Durham, NC
Baliopharm Venture Capital-Backed Basel, Switzerland
Visterra Venture Capital-Backed Waltham, MA
You’re viewing 5 of 47 competitors. Get the full list »

Atox Bio Patents

Atox Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2014358677-A1 Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 Inactive 06-Dec-2013
AU-2017261479-A1 Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 Active 06-Dec-2013
AU-2017261479-B2 Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 Inactive 06-Dec-2013
CA-2932150-A1 Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 Inactive 06-Dec-2013
EP-3077415-A1 Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through cd28 Active 06-Dec-2013 C07K14/70521
To view Atox Bio’s complete patent history, request access »

Atox Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Atox Bio FAQs

  • When was Atox Bio founded?

    Atox Bio was founded in 2002.

  • Where is Atox Bio headquartered?

    Atox Bio is headquartered in Durham, NC.

  • What is the size of Atox Bio?

    Atox Bio has 10 total employees.

  • What industry is Atox Bio in?

    Atox Bio’s primary industry is Drug Discovery.

  • Is Atox Bio a private or public company?

    Atox Bio is a Private company.

  • What is Atox Bio’s current revenue?

    The current revenue for Atox Bio is .

  • How much funding has Atox Bio raised over time?

    Atox Bio has raised $61.4M.

  • Who are Atox Bio’s competitors?

    AnTolRx, Xalud Therapeutics, Parion Sciences, Baliopharm, and Visterra are some of the 47 competitors of Atox Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process